Fusen Pharmaceutical Company Limited (1652.HK)
1652.HK Stock Price Chart
Explore Fusen Pharmaceutical Company Limited interactive price chart. Choose custom timeframes to analyze 1652.HK price movements and trends.
1652.HK Company Profile
Discover essential business fundamentals and corporate details for Fusen Pharmaceutical Company Limited (1652.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
11 Jul 2018
Employees
1.13K
Website
https://www.fusenyy.comCEO
Zhiming Cao
Description
Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
1652.HK Financial Timeline
Browse a chronological timeline of Fusen Pharmaceutical Company Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Mar 2025
EPS came in at -$0.11 , while revenue for the quarter reached $68.99M .
Earnings released on 30 Sept 2024
EPS came in at -$0.11 , while revenue for the quarter reached $71.76M .
Earnings released on 30 Aug 2024
EPS came in at -$0.03 , while revenue for the quarter reached $105.42M .
Earnings released on 28 May 2024
EPS came in at -$0.03 , while revenue for the quarter reached $106.20M .
Earnings released on 29 Mar 2024
EPS came in at -$0.04 , while revenue for the quarter reached $126.82M .
Earnings released on 22 Jan 2024
EPS came in at -$0.04 , while revenue for the quarter reached $122.90M .
Earnings released on 30 Aug 2023
EPS came in at $0.01 , while revenue for the quarter reached $192.02M .
Earnings released on 30 Jun 2023
EPS came in at $0.01 , while revenue for the quarter reached $181.92M .
Earnings released on 29 Mar 2023
EPS came in at -$0.02 , while revenue for the quarter reached $179.14M .
Earnings released on 31 Dec 2022
EPS came in at -$0.02 , while revenue for the quarter reached $185.73M .
Earnings released on 29 Aug 2022
EPS came in at -$0.01 , while revenue for the quarter reached $102.05M .
Earnings released on 30 Jun 2022
EPS came in at -$0.01 , while revenue for the quarter reached $96.94M .
Dividend declared on 7 Jun 2022
A dividend of $0.00 per share was announced, adjusted to $0.00. The dividend was paid on 30 Jun 2022.
Earnings released on 31 Dec 2021
EPS came in at -$0.02 , while revenue for the quarter reached $104.96M .
Earnings released on 30 Sept 2021
EPS came in at -$0.02 , while revenue for the quarter reached $103.40M .
Dividend declared on 17 Sept 2021
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 19 Nov 2021.
Earnings released on 30 Jun 2021
EPS came in at $0.03 , while revenue for the quarter reached $128.60M .
Dividend declared on 8 Jun 2021
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 16 Jul 2021.
Earnings released on 31 Mar 2021
EPS came in at $0.03 , while revenue for the quarter reached $126.83M .
Earnings released on 31 Dec 2020
EPS came in at $0.03 , while revenue for the quarter reached $142.13M .
Earnings released on 30 Sept 2020
EPS came in at $0.03 , while revenue for the quarter reached $136.46M .
Dividend declared on 15 Sept 2020
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 27 Nov 2020.
1652.HK Stock Performance
Access detailed 1652.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.